Drug Profile
Fosalvudine tidoxil
Alternative Names: HDP 99.0003; HDP-990003Latest Information Update: 13 Oct 2017
Price :
$50
*
At a glance
- Originator Heidelberg Pharma
- Class Antivirals; Dideoxynucleosides
- Mechanism of Action Nucleoside reverse transcriptase inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- Discontinued HIV infections
Most Recent Events
- 09 Oct 2017 Heidelberg Pharma is now called Heidelberg Pharma Research
- 09 Feb 2011 Discontinued - Phase-II for HIV infections in Argentina (PO)
- 09 Feb 2011 Discontinued - Phase-II for HIV infections in Germany (PO)